Quick Answer: What Is the Depo-Provera Lawsuit Deadline in Philadelphia, PA?

Pennsylvania claims are generally screened against a 2-year filing framework. For Depo-Provera meningioma cases, the key deadline question is usually when you were diagnosed, when you reasonably connected the diagnosis to Depo-Provera use, and whether any discovery-rule or tolling arguments apply under Pennsylvania law.

Because deadline analysis depends on diagnosis dates, injection history, and medical records, Philadelphia residents should not assume they are too early or too late without a case-specific review.

Depo-Provera Meningioma Claims in Philadelphia, Pennsylvania

Thousands of women across the United States — including residents of Philadelphia, Philadelphia County — have filed lawsuits against Pfizer after being diagnosed with intracranial meningiomas linked to long-term Depo-Provera use. These brain tumors, though often considered "benign," can cause serious neurological damage, require surgery or radiation, and significantly diminish quality of life.

Scientific research, including a landmark 2024 French pharmacovigilance study published in the British Medical Journal, confirmed a four-fold increased risk of meningioma in women who used high-dose progestins like Depo-Provera for more than one year. The FDA subsequently updated Depo-Provera's labeling to include a meningioma warning — a step critics say was years overdue.

With a population of approximately 1,550,542, Philadelphia is one of Pennsylvania's communities where women who relied on Depo-Provera for long-term contraception are now seeking accountability.

What Is a Meningioma?

A meningioma is a tumor that forms in the meninges — the protective membranes surrounding the brain and spinal cord. While classified as benign in most cases, meningiomas can grow large enough to compress brain tissue and cause:

  • Persistent or worsening headaches
  • Vision problems, including blurred or double vision
  • Hearing loss or tinnitus
  • Cognitive difficulties, memory loss, or personality changes
  • Seizures
  • Weakness or numbness in arms and legs

Many women in Philadelphia and surrounding Philadelphia County communities who underwent neurosurgery or radiation for meningioma may not have been told — until recently — that their birth control injection could be responsible.

How Depo-Provera Is Linked to Brain Tumors

Depo-Provera delivers 150 mg of medroxyprogesterone acetate (MPA) in a single intramuscular injection administered every three months. Unlike lower-dose progestin-only pills, the injection creates sustained, high-level hormonal exposure. Meningiomas are known to have progesterone receptors, and long-term, high-dose progestin stimulation is now understood to accelerate their growth.

Medical researchers, including those who published findings in the BMJ and other peer-reviewed journals, found that women who received Depo-Provera injections for more than 12 months had approximately four times the baseline risk of developing a meningioma compared to non-users. For women in Philadelphia who received injections over many years — as commonly recommended for long-term contraception — the cumulative exposure could be significant.

Pfizer continued marketing Depo-Provera without a meningioma warning for years after this risk became apparent in scientific literature. Lawsuits allege that this failure to warn constitutes negligence and that Pfizer knew or should have known about the elevated risk far earlier than it disclosed it.

Pennsylvania Filing Deadline — Act Before Time Runs Out

Statute of Limitations in Pennsylvania: 2 Years
Rule Type: discovery rule (clock starts when you reasonably knew)

Pennsylvania generally has a 2-year limitations period and recognizes discovery-rule accrual in appropriate latent injury cases.

The statute of limitations sets a hard deadline for filing a Depo-Provera lawsuit in Pennsylvania. Missing this deadline typically means losing your right to compensation — permanently. For Philadelphia residents, the clock may have started when you were diagnosed with a meningioma, or when you reasonably should have connected your diagnosis to your Depo-Provera use. Because this analysis depends on your specific facts, it's critical to speak with an attorney sooner rather than later.

Important: Even if you're unsure how long ago your diagnosis occurred, do not assume you've missed the deadline. Tolling provisions, fraudulent concealment arguments, and discovery-rule exceptions may extend your filing window in Pennsylvania. A case review is free and takes only minutes.

Start Your Free Philadelphia Case Review →

Federal MDL 3140 — Where Philadelphia Cases Are Filed

Depo-Provera meningioma cases from across the country — including Philadelphia, Pennsylvania — are being consolidated in a federal Multidistrict Litigation (MDL) proceeding: MDL No. 3140 in the U.S. District Court for the Northern District of California. This consolidation does not mean you must travel to California. Your attorney handles all filings and court appearances remotely.

MDL consolidation benefits plaintiffs by sharing discovery costs, streamlining expert testimony, and creating leverage for bellwether trial results that inform settlement negotiations. Philadelphia residents who file as part of MDL 3140 benefit from this coordinated litigation infrastructure while still retaining their individual claims.

Who Qualifies for a Depo-Provera Lawsuit from Philadelphia?

To be eligible, you generally need to meet these criteria:

  • Depo-Provera use: You received Depo-Provera or generic medroxyprogesterone acetate injections for 12 months or longer
  • Meningioma diagnosis: You have been diagnosed with an intracranial meningioma confirmed by MRI, CT scan, biopsy, or surgery
  • Causal link: Your meningioma occurred during or after Depo-Provera use (not all meningiomas are eligible)
  • Damages: Your meningioma required or will require medical treatment — surgery, radiation, or ongoing monitoring
  • Timeliness: Your claim was filed within Pennsylvania's 2-year statute of limitations (from diagnosis or discovery)

Even if you moved away from Philadelphia after your diagnosis, you may still qualify if your injections were received in Pennsylvania or if Pennsylvania has jurisdiction over your claim. Call for a free case review to determine your eligibility.

What Compensation Is Available?

Depo-Provera plaintiffs may be eligible to recover:

  • Medical expenses: Surgery, radiation, MRIs, neurology visits, post-operative care, medications
  • Future medical costs: Ongoing monitoring, potential repeat surgery, long-term neurological care
  • Lost wages: Income lost while undergoing treatment or recovering from surgery
  • Loss of earning capacity: If your career was disrupted by cognitive or physical symptoms
  • Pain and suffering: Physical pain, emotional distress, and diminished quality of life
  • Loss of consortium: Impact on your personal and family relationships

Settlement amounts in mass tort litigation vary based on the severity of your meningioma, the extent of treatment required, and your specific damages. An attorney can evaluate your case and provide an honest estimate of its value.

Nearby Pennsylvania Cities Also Filing Claims

Residents from across Philadelphia County and nearby Pennsylvania communities are also pursuing Depo-Provera meningioma claims:

If you are located in Philadelphia or anywhere in Philadelphia County, the same filing rules and MDL process apply. Distance from a courthouse is not a barrier to filing.

How to Start Your Claim from Philadelphia

  1. Gather your records: Collect pharmacy records, OB-GYN records showing Depo-Provera injections, and MRI/CT reports confirming your meningioma diagnosis.
  2. Complete our eligibility form: Takes about 3 minutes. You'll tell us when you used Depo-Provera, when you were diagnosed, and what treatment you received.
  3. Free attorney consultation: A mass tort attorney specializing in Depo-Provera cases will review your information at no cost to you.
  4. File your claim: If eligible, your attorney files your case — either in MDL 3140 or in state court depending on your situation. You pay nothing unless you win.

The entire process can be handled from Philadelphia without traveling to any courthouse. Most communication is done by phone or email.

⏰ Time is Running Out for Philadelphia Residents

Pennsylvania's 2-year statute of limitations means eligible Philadelphia residents could permanently lose their right to compensation if they wait too long to file. The case review is free, confidential, and takes only a few minutes.

Check Eligibility Now — Philadelphia, PA →

Frequently Asked Questions — Philadelphia

Do I need to hire a local Philadelphia attorney?

No. Depo-Provera cases are handled federally in MDL 3140. Many plaintiffs work with mass tort law firms that specialize in these cases — regardless of where you live. You don't need a Philadelphia-specific attorney.

What if my meningioma was small or didn't require surgery?

You may still qualify. Some meningioma cases involve "watchful waiting" or periodic MRI monitoring rather than immediate surgery. The key is that your tumor was diagnosed and is linked to Depo-Provera use. An attorney can evaluate whether your diagnosis meets the case criteria.

How long does the Depo-Provera lawsuit process take?

MDL litigation typically unfolds over 2–4 years from filing to settlement or verdict. Bellwether trials are expected to begin in 2026 and will signal whether global settlements are imminent. Filing early is advantageous — it preserves evidence and positions your claim favorably.

Is there a cost to file?

No upfront cost. Depo-Provera attorneys work entirely on contingency — meaning they only receive payment if you recover compensation. There is no fee to submit an eligibility inquiry or speak with an attorney.

Take the Next Step